Skin testing (limited to patients with diagnosis of anaphylaxis) Skin testing (limited to patients with diagnosis of anaphylaxis) Skin testing (limited to patients with diagnosis of anaphylaxis) 17/69
Polysorbate positive Polysorbate positive 1/7
Polysorbate negative Polysorbate negative 6/7
Macrogol negative Macrogol negative 12/12
Tromethamine negative Tromethamine negative 1/1
Administered vaccine Administered vaccine Administered vaccine Administered vaccine
Comirnaty® Comirnaty® 57/69
Jcovden® Jcovden® 9/69
Vaxzevria® Vaxzevria® 3/69
Symptoms immediately after vaccination Symptoms immediately after vaccination Symptoms immediately after vaccination 2/69
Anaphylaxis (dyspnea, urticaria) 1/2
Urticaria 1/2
Symptoms after administration of placebo Symptoms after administration of placebo Symptoms after administration of placebo 19/69
Subjective feeling of pharyngeal swelling 4/19
Generalized malaise 4/19
Headache 3/19
Pruritus 3/19
Thoracal pain 3/19
Nausea 4/19
Syncope 1/19
Palpitations 4/19
Symptoms after placebo per referral group Symptoms after placebo per referral group Symptoms after placebo per referral group Symptoms after placebo per referral group
Anxiety 4/23
Symptoms after 1st or 2nd dose 14/41
Multiple anaphylaxis 0/1
Refused by vaccination center 1/4